ABSTRACT
Relapsing polychondritis (RP) is an uncommon multisystem disorder characterized by recurrent episodes of inflammation and progressive destruction of cartilaginous tissues (1). The clinical course can range from a relatively benign disease to one that is fulminant, causing death within months of disease onset. There is no serologic test that is diagnostic or predictive of the severity of the clinical course. Treatment is empiric and tailored to the clinical presentation.
